797 related articles for article (PubMed ID: 12922924)
1. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
Schnackenberg CG; Merz E; Brooks DP
Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
[TBL] [Abstract][Full Text] [Related]
2. CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.
Gellai M; Schreiner GF; Ruffolo RR; Fletcher T; DeWolf R; Brooks DP
J Pharmacol Exp Ther; 1998 Sep; 286(3):1191-6. PubMed ID: 9732378
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of the action of diuretics in the newborn pig.
Noordewier B; Bailie MD; Hood JB
J Pharmacol Exp Ther; 1978 Oct; 207(1):236-42. PubMed ID: 702345
[TBL] [Abstract][Full Text] [Related]
5. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ROMK blocks macula densa tubuloglomerular feedback yet causes renal vasoconstriction in anesthetized rats.
Araujo M; Welch WJ; Zhou X; Sullivan K; Walsh S; Pasternak A; Wilcox CS
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1120-F1127. PubMed ID: 28228405
[TBL] [Abstract][Full Text] [Related]
8. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.
Knauf H; Mutschler E
J Cardiovasc Pharmacol; 1995 Sep; 26(3):394-400. PubMed ID: 8583780
[TBL] [Abstract][Full Text] [Related]
9. Renal action of a novel uricosuric diuretic, S-8666. I. Clearance and tubular microinjection studies in rats.
Shimuizu T; Nakamura M; Imai M
J Pharmacol Exp Ther; 1988 May; 245(2):644-50. PubMed ID: 3367310
[TBL] [Abstract][Full Text] [Related]
10. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT
Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047
[TBL] [Abstract][Full Text] [Related]
11. Effects of cicletanine on kidney function. 1. Clearance and micropuncture studies in anesthetized rats.
Greven J
J Pharmacol Exp Ther; 1995 Jun; 273(3):1190-6. PubMed ID: 7791090
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological and toxicological properties of the saluretic xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide)].
Leuschner F; Neumann W; Bahrmann H
Arzneimittelforschung; 1975 Feb; 25(2):245-51. PubMed ID: 1173041
[TBL] [Abstract][Full Text] [Related]
13. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
[TBL] [Abstract][Full Text] [Related]
14. A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.
Jackson EK; Kost CK; Herzer WA; Smits GJ; Tofovic SP
J Pharmacol Exp Ther; 2001 Dec; 299(3):978-87. PubMed ID: 11714886
[TBL] [Abstract][Full Text] [Related]
15. Renal responses to diuretic drugs in freshwater catfish Ictalurus punctatus.
Nishimura H
Am J Physiol; 1977 Mar; 232(3):F278-85. PubMed ID: 842674
[TBL] [Abstract][Full Text] [Related]
16. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
Franson KL; Kuk JM; Lam NP; Lau AH
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
[TBL] [Abstract][Full Text] [Related]
17. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
[TBL] [Abstract][Full Text] [Related]
18. Acute diuretic effect of continuous intravenous infusion of an aqueous extract of Coriandrum sativum L. in anesthetized rats.
Aissaoui A; El-Hilaly J; Israili ZH; Lyoussi B
J Ethnopharmacol; 2008 Jan; 115(1):89-95. PubMed ID: 17961943
[TBL] [Abstract][Full Text] [Related]
19. Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics.
Meariman JK; Sutphen JC; Gao J; Kapusta DR
Hypertension; 2022 Feb; 79(2):379-390. PubMed ID: 34852633
[TBL] [Abstract][Full Text] [Related]
20. CL 65,562 (4-(a,a,a-trifluoro-m-toluidino)-nicotinic acid), a novel "high ceiling" diuretic.
Gussin RZ; Cummings JR; Stokey EH; Ronsberg MA
J Pharmacol Exp Ther; 1969 May; 167(1):194-206. PubMed ID: 5814494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
